Investing $10,000 in Monster Beverage Stock 10 Years Ago Paid Off More Than Investing the Same Amount in Coca-Cola. Here's the Better Buy for the Next Decade.
Source: Nasdaq

Monster Beverage delivered a 258.9% total return over the past decade versus 179.3% for Coca-Cola, supported by revenue growth from $3.05B in 2016 to about $9.2B in 2025. Coca-Cola has led in 2026, returning more than 27% year-to-date versus 14.8% for Monster, aided by a sales-growth rebound and nearly 10% EPS growth. Monster posted 20.2% Q2 2026 sales growth and 19% EPS growth, but its 34x forward P/E leaves it more exposed to a valuation de-rating than Coca-Cola at 25x forward earnings; Coke also offers a 2.4% dividend yield.
Analysis
The relevant question is not historical relative returns but whether KO's recent growth rate can clear a valuation that now embeds durable execution. KO's incremental upside depends on price/mix, international volume and bottler-system economics persisting simultaneously; a normalization toward its low-single-digit organic-growth profile would leave limited support for further multiple expansion. Its defensive characteristics and dividend make KO relatively attractive if consumer staples flows continue, but the risk/reward becomes asymmetric after a sharp rerating.
MNST has a more favorable operating-growth setup but a less forgiving stock setup. At a premium earnings multiple, the market will focus on sequential category growth, U.S. share trends and gross-margin conversion rather than headline revenue alone; any evidence that promotional intensity or aluminum/sweetener costs are absorbing growth can compress the multiple faster than earnings estimates fall. Celsius (CELH), Red Bull's private-market pressure, and PepsiCo's expanding energy distribution are more relevant competitive variables than KO.
Near term, this is primarily a positioning and valuation-spread trade rather than a new fundamental discovery. Over 1-3 months, MNST needs sustained high-teens sales growth and stable margins to reassert leadership; KO needs another guidance raise or evidence that volume—not merely pricing—is carrying results. Over 6-18 months, energy-drink penetration and international distribution favor MNST, while KO's broader portfolio and pricing power better protect downside in a consumer slowdown.
Contrarian view: the apparent KO/MNST valuation gap is not sufficient by itself to favor KO. If MNST's growth remains materially above the category, a premium multiple can persist; conversely, KO is exposed to a crowded quality/defensive trade unwinding if rates rise or staples inflows reverse. The key falsifier for a MNST-underperformance thesis is continued high-teens organic growth with no gross-margin erosion through the next two earnings reports.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
Key Decisions for Investors
- Maintain a modest long MNST / short KO dollar-neutral pair only after a further 5-8% widening in MNST's valuation premium or a MNST earnings-related rally; target 10-15% relative return over 3-6 months. Stop if MNST delivers two consecutive quarters of high-teens growth with expanding gross margin, or KO cuts organic-growth guidance.
- For defensive consumer exposure over the next 1-3 months, retain KO rather than adding aggressively: use a 7-10% pullback from current levels to add. Upside requires another earnings/guidance revision; a reversal in staples fund flows or evidence of volume deterioration is the exit signal.
- Do not short MNST outright ahead of results. Set an alert for deceleration below low-teens sales growth, rising promotional expense, or gross-margin compression; those conditions would support a 3-6 month short or put-spread position as the premium multiple resets.
- Monitor CELH relative performance and energy-category scanner data as leading indicators. CELH share stabilization alongside softer MNST U.S. growth would increase conviction in the MNST short leg; continued MNST outperformance despite category competition invalidates the trade.
More News
- Nscale wants a $35 billion valuation. Nvidia is helping foot the bill
- This stock’s defensive appeal faces a valuation test. Here's where else investors can look
- 6 Things to Know About Anthropic's Upcoming IPO
- Why Kinross Gold Stock Is Crashing Today
- Lovable’s annualized revenue crosses $600M as vibe coding takes off
- Why Iovance Biotherapeutics Stock Was on Fire Today
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: In-App Tutorials, Futures Data, and Watchlist Enhancements
- AI Tools for Independent Research Firms: A Publishing System